FOR INVESTORS & PARTNERS
An early-stage vision.
An evidence-led path.
Neurabi is developing microbiome research tools for a possible future role in neurological care. The immediate priority is the pilot and the evidence needed to assess that opportunity.
In development · Pilot study in preparationThe proposed business model
A future clinician-facing service combining microbiome analysis and interpretation, with a potential recurring platform model for clinical partners. Pricing, laboratory arrangements and commercial access remain to be defined and validated.
What we are working towards
- ↗A feasible pilot protocol with appropriate clinical and ethical oversight.
- ↗Research methods that make evidence and uncertainty understandable.
- ↗Evidence to inform subsequent clinical and regulatory decisions.
OUR JOURNEY
Where we are,
and what comes next.
Four milestones, from the prototype that exists today to a service that would follow validation. Timing depends on research findings, partnerships and the necessary approvals.
- ✓DONE SO FAR
A working prototype
The research method, the portal and clinician review have been built and tested with example data.
- WE ARE HERE
Preparing the pilot
Agreeing the study protocol, laboratory arrangements and clinical input, and preparing for the required approvals.
- NEXT
Learn from a first study
Run the pilot once approved, with follow-up and repeat samples, to find out whether this is feasible and useful.
- LONGER TERM
Prove it before offering it
Further validation and any regulatory steps would come before a service could become available.
THE NEXT CHAPTER STARTS WITH A QUESTION.
Let’s understand
more, together.
A clinician, a researcher, a patient organisation, or simply curious? We’d like to hear from you.
Get in touch